Clinical importance of weight gain and associated factors in patients with moderate to severe ulcerative colitis : results from the MOSAIK cohort in Korea
© 2023. The Author(s)..
BACKGROUND: Many patients with ulcerative colitis (UC) gain weight after treatment. However, the clinical significance of weight gain in these patients remains unclear. This study aimed to evaluate body weight changes after treatment in patients newly diagnosed with moderate-to-severe UC and their effects on patients' prognosis.
METHODS: The change in weight between diagnosis and 1 year after treatment in 212 patients enrolled in the MOSAIK cohort (mean age, 40 years; males, 60%) was analyzed. Significant weight gain was defined as a weight increase of ≥ 5% from the baseline at 1 year. Factors associated with significant weight gain and the effect of significant weight gain on the risk of major adverse outcomes (clinical relapse, hospitalization, and new use of steroids or biologics) during a follow-up period of 20 months were evaluated.
RESULTS: Mean weight gain at 1 year was 1.7 ± 4.2 kg. The proportion of overweight/obese patients increased by 9.0% from 37.9% to 46.9%. Thirty-two percent had significant weight gain; extensive colitis at diagnosis was the only factor associated with significant weight gain (odds ratio 6.5, 95% confidence interval 1.4-31.0, p = 0.006). In multivariable analysis, significant weight gain was not associated with the risk of major adverse outcomes. Weight loss symptoms at diagnosis were associated with an increased risk for new steroid use after 1 year.
CONCLUSIONS: Approximately one-third of patients with moderate-to-severe UC had significant weight gain after 1 year of treatment. However, significant weight gain was not associated with the patient's prognosis.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:23 |
|---|---|
| Enthalten in: |
BMC gastroenterology - 23(2023), 1 vom: 21. Nov., Seite 405 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Yoon, Hyuk [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 27.11.2023 Date Revised 27.11.2023 published: Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1186/s12876-023-03008-7 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM364814357 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM364814357 | ||
| 003 | DE-627 | ||
| 005 | 20231226100238.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/s12876-023-03008-7 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1215.xml |
| 035 | |a (DE-627)NLM364814357 | ||
| 035 | |a (NLM)37990156 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Yoon, Hyuk |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Clinical importance of weight gain and associated factors in patients with moderate to severe ulcerative colitis |b results from the MOSAIK cohort in Korea |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 27.11.2023 | ||
| 500 | |a Date Revised 27.11.2023 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2023. The Author(s). | ||
| 520 | |a BACKGROUND: Many patients with ulcerative colitis (UC) gain weight after treatment. However, the clinical significance of weight gain in these patients remains unclear. This study aimed to evaluate body weight changes after treatment in patients newly diagnosed with moderate-to-severe UC and their effects on patients' prognosis | ||
| 520 | |a METHODS: The change in weight between diagnosis and 1 year after treatment in 212 patients enrolled in the MOSAIK cohort (mean age, 40 years; males, 60%) was analyzed. Significant weight gain was defined as a weight increase of ≥ 5% from the baseline at 1 year. Factors associated with significant weight gain and the effect of significant weight gain on the risk of major adverse outcomes (clinical relapse, hospitalization, and new use of steroids or biologics) during a follow-up period of 20 months were evaluated | ||
| 520 | |a RESULTS: Mean weight gain at 1 year was 1.7 ± 4.2 kg. The proportion of overweight/obese patients increased by 9.0% from 37.9% to 46.9%. Thirty-two percent had significant weight gain; extensive colitis at diagnosis was the only factor associated with significant weight gain (odds ratio 6.5, 95% confidence interval 1.4-31.0, p = 0.006). In multivariable analysis, significant weight gain was not associated with the risk of major adverse outcomes. Weight loss symptoms at diagnosis were associated with an increased risk for new steroid use after 1 year | ||
| 520 | |a CONCLUSIONS: Approximately one-third of patients with moderate-to-severe UC had significant weight gain after 1 year of treatment. However, significant weight gain was not associated with the patient's prognosis | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Risk factors | |
| 650 | 4 | |a Ulcerative colitis | |
| 650 | 4 | |a Weight gain | |
| 700 | 1 | |a Park, Young Soo |e verfasserin |4 aut | |
| 700 | 1 | |a Shin, Jeong Eun |e verfasserin |4 aut | |
| 700 | 1 | |a Ye, Byong Duk |e verfasserin |4 aut | |
| 700 | 1 | |a Eun, Chang Soo |e verfasserin |4 aut | |
| 700 | 1 | |a Yoon, Soon Man |e verfasserin |4 aut | |
| 700 | 1 | |a Cha, Jae Myung |e verfasserin |4 aut | |
| 700 | 1 | |a Kim, You Sun |e verfasserin |4 aut | |
| 700 | 1 | |a Huh, Kyu Chan |e verfasserin |4 aut | |
| 700 | 1 | |a Park, Young Sook |e verfasserin |4 aut | |
| 700 | 1 | |a Cheon, Jae Hee |e verfasserin |4 aut | |
| 700 | 1 | |a Jung, Eun Suk |e verfasserin |4 aut | |
| 700 | 1 | |a Kim, Youngdoe |e verfasserin |4 aut | |
| 700 | 1 | |a Jung, Su Young |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t BMC gastroenterology |d 2001 |g 23(2023), 1 vom: 21. Nov., Seite 405 |w (DE-627)NLM110904761 |x 1471-230X |7 nnns |
| 773 | 1 | 8 | |g volume:23 |g year:2023 |g number:1 |g day:21 |g month:11 |g pages:405 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1186/s12876-023-03008-7 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 23 |j 2023 |e 1 |b 21 |c 11 |h 405 | ||